USPTO serial 79289279
NATURALIFE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 5, 2023
- Examiner
- BRADLEY, EVELYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NATURALIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindy M. Herman
Lindy M. Herman Rutan & Tucker, LLP18575 Jamboree Road, 9th FloorIrvine, CA 92612UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Apparatus for scientific and laboratory research, namely, incubators; laboratory apparatus and instruments, namely, microfluidic biochips for gamete denudation, fertilization, embryo development and image capture, for research and scientific purposes; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biologics | ACTIVE | — |
| 010 | Instruments for medical analysis relating to the treatment of persons, namely, mass spectrometers for analyzing biomarkers and identifying metabolomics profiling, genetic blueprint, aneuploidy screening, genetic abnormalities screening and for pregnancy and miscarriage likelihood screening; medical diagnostic apparatus for detecting embryo DNA, metabolites, proteins, morphological quality assessment of cleavage stage embryos and blastocysts for pregnancy and miscarriage likelihood; medical diagnostic apparatus for diagnosis, examination and monitoring embryos; medical diagnostic apparatus for tracking embryo development; medical diagnostic apparatus for embryo image assessment, specifically for analyzing microscopy images of developing embryos and medical imaging apparatus for diagnosing medical conditions during the process of in-vitro fertilization and incorporating recorded operating system software | ACTIVE | — |
| 042 | Design and testing of new products for others; design and testing for new product development; scientific and technological services, namely, scientific research; product development in the field of assisted reproductive technologies; design and development of products in the field of embryology, assisted reproductive technologies research; development of new products; scientific research and development; development of medical testing methods; product development analysis; product development evaluation; research and development of new products; design and development of medical technology; biological research; clinical research in the field of in vitro fertilization, clinical reproduction and medical diagnostics; medical research; scientific research with a medical purpose; research and development in the field of pharmacy and biotechnology; development and design of new products; scientific and technological design in the field of assisted reproductive technologies; specialized machinery design; design of new products; new product design; scientific research and design in the field of in vitro fertilization, automatic time-lapse incubators, microscopes, micromanipulators, embryo culture, labware, and gamete processing methods; research relating to design in the field of assisted reproductive technologies; medical research relating to human tissue; medical and scientific research, namely, conducting clinical trials for others; clinical studies being clinical research in the field of in Vitro Fertilization, embryology, clinical reproduction, fertility and infertility services and medical diagnostic; clinical research in the field of tissue engineering of artificial placenta; artificial endometrium research in the field of pharmacogenetics; medical research; medical laboratory services; biomedical research services; technological analysis and evaluation of products during product development to determine efficacy and conformity with certification standards; computer aided design of molds | ACTIVE | — |
| 044 | In vitro fertilization services; medical services, specifically, in-vitro fertilization; analysis of human tissues for medical treatment; medical analysis for the diagnosis and treatment of people; medical consultancy in the field of pregnancy; medical assistance; medical care; medical consultations; gynecological cytology services; medical examination for persons; medical information; medical analysis services for diagnostic and treatment purposes; medical and healthcare services related to DNA, genetics and genetic testing; sperm bank services; human fertility treatment services; pregnancy testing services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Overture Life, Inc
- Other trademarks owned by Overture Life, Inc
- Other trademarks owned by Overture Life, Inc
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NATURALIFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 5, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 5, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 5, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 5, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 30, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 30, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 30, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 16, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 12, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 12, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 12, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 12, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 20, 2023 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jan 20, 2023 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jan 20, 2023 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Nov 21, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 8, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 12, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 12, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 12, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 23, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 22, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 22, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 1, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 15, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 15, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 20, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 20, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 20, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 13, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 2, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 2, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 8, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 8, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 20, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 19, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |